Cytek Biosciences, Inc.
NASDAQ:CTKB
6.83 (USD) • At close January 8, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Cytek Biosciences, Inc. |
Symbool | CTKB |
Munteenheid | USD |
Prijs | 6.83 |
Beurswaarde | 879,779,130 |
Dividendpercentage | 0% |
52-weken bereik | 4.66 - 9.328 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Dr. Wenbin Jiang Ph.D. |
Website | https://cytekbio.com |
An error occurred while fetching data.
Over Cytek Biosciences, Inc.
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)